The life sciences group at Pérez-Llorca is well-versed in assisting laboratories, pharma companies and medical device manufacturers with procurement, competition law, IP and transactional matters in the life sciences space. Leadership of the team is shared between Eduardo Castillo, who specialises in patent litigation, and Juan Rodríguez Cárcamo, who focuses on public law and regulatory matters. Also noted is administrative law specialist Natalia Olmos, who frequently assists with asset liability claims. Rais Amils left the firm in December 2024.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Sector knowledge
Testimonials
Collated independently by Legal 500 research team.
- ‘Availability and closeness to the customer.’
- ‘Collaboration and closeness with the client.’
Key clients
- Bristol-Myers Squibb
- MGI
- Abbott Diabetes Care
- Fremman Capital
- Acurio Ventures
- Oxy Capital
- Romano Senior
- ANI Pharmaceuticals
- Arkéa REIM
- PharmaMar
Work highlights
Advised PharmaMar on the sale of a part of its genetics division to Citogen, a Spanish laboratory specialising in clinical and forensic genetics.
Advising BMS on a series of legal actions that include a revocation action, an infringement lawsuit, and precautionary measures against Teva, one of the leading generic pharmaceutical companies worldwide.
Advising Siemens Healthineers on a matter regarding Spanish competition, litigation and corporate law, relating to liability for damages arising from a decision of the National Commission on Markets and Competition (CNMC).
Practice head
Eduardo Castillo; Juan Rodríguez Cárcamo
Other key lawyers
Natalia Olmos; Cristina Caínzos; Joaquín Rovira